Drug Information Update- New Risk Evaluation and Mitigation Strategies website provides centralized, user-friendly source for approved REMS

Approved Risk Evaluation and Mitigation Strategies (REMS)

The Division of Drug Information (DDI) is CDER's focal point for public inquiries. We serve the public by providing information on human drug products and drug product regulation by FDA.

Yesterday the U.S. Food and Drug Administration launched its new online resource REMS@FDA to provide the public with information about currently approved individual and shared system REMS as well as historical and released REMS.

To learn more, please visit: REMS@FDA.